Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Antibiotic resistance
Audience-Senior Medical Officers Venue- Pune Date- 9th May 2011
Dr.J.Nuchin. MD,MBA
Antimicrobial drug
An anti-microbial is a substance that kills (microbiocidal) or inhibits (microbiostatic) the growth of microorganisms such as bacteria, viruses, fungi, or protozoans. Antibiotics are the sub-group of antimicrobial drugs that act against bacteria. Like that antiviral, chemotherapeutic agents,antifungal and antiparasites are named. Antiseptics are antimicrobial substances that are applied to living tissue/skin to reduce the possibility of infection, sepsis, or putrefaction. Disinfectants are antimicrobial substances used on nonliving objects or outside the body.
Technically, antibiotics are only those substances that are produced by one microorganism that kill, or prevent the growth, of another microorganism. Of course, in today's common usage, the term antibiotic is used to refer to almost any drug that attempts to rid your body of a bacterial infection. Thus, antimicrobials include not just antibiotics, but synthetically formed compounds as well. The discovery of antimicrobials is one of the most important advances in health in human history alleviating suffering from disease and saving billions of lives over the past 70 years.
History of Antimicrobials
The history of antimicrobials begins with the observations of Pasteur and Joubert, who discovered that one type of bacteria could prevent the growth of another. They did not know at that time that the reason one bacterium failed to grow was that the other bacterium was producing an antibiotic. Alexander Fleming (1928) was the first to suggest that the Penicillium mould secrete an antibacterial substance, and the first to isolate the active substance which he named penicillin, but he was not the first to use its properties in man.
Howard Walter Florey, Baron Florey, an Australian pharmacologist and pathologist extracted the penicillin and used on humans. He shared the Nobel Prize in Medicine in 1945 with Sir Ernst Boris Chain and Sir Alexander Fleming for his role in the extraction of penicillin. In 1940, he treated his first patient, Albert Alexander, who had been scratched by a rose thorn. His whole face, eyes, scalp were swollen, and he had an eye removed to relieve some of the pain. Within a day of being given penicillin, he started recovering. However they did not have enough penicillin to help him to full recovery, he relapsed, and died.
Penicillin
Fleming 1928
7
Albert Alexander
First Patient who received Penicillin
The discovery of antimicrobials like penicillin(1927) and tetracycline (1948 produced by the Streptomyces genus of Actinobacteria ) paved the way for better health for millions around the world. Before penicillin became a viable medical treatment in the early 1940s, no true cure for gonorrhea, strep throat, or pneumonia existed. Patients with infected wounds often had to have a wounded limb removed, or face death from infection. Now, most of these infections can be cured easily with a short course of antimicrobials.
History of resistance
1941 Penicillin 1943 Streptomycin 1945 Cephalosporins 1950 Tetracyclines 1952 Eryrthromycin 1956 Vancomycin
Methicillin Lincomycin Quinolones Penems Monobactams The end of the antibiotic era?
10
The emergence of resistance to such drugs is a natural biological phenomenon. Microbes are living organisms that evolve over time. Their primary function is to reproduce, thrive, and spread, quickly and efficiently. Therefore, microbes adapt to their environment and change in ways that ensure their survival. If something stops their ability to spread, such as an antimicrobial, genetic changes can occur that enable the microbe to survive. There are several ways this happens.
Although the natural phenomenon by which resistance emerges can be accelerated and amplified by a variety of factors, the most important cause is the inappropriate and injudicious use of antimicrobials in humans, animals, and agriculture.
In veterinary use
Discuss in detail
Genetic transfer to human specific organisms (avoparcin in pigs and chickens). This can also occur with plant bacteria.
Ampicillin
Buquinolate
Erythromycin
Monensin
Penicillin
Tiamulin
Sulfamethazine
Amprolium
Carbadox
Fluoroquinilon es
Narasin
Penecillin/Streptomyc in
Tilmicosin
Sulfamethoxine
Apramycin
Ceftiofur
Furamazone
Neomycin
Robenidine
Tylosin
Sulfamyxin
Arsanilate
Chlortetracycline
Gentamycin
Nequinate
Roxarsone
Sulfabromomethazi ne
Sulfanitran
Arsanilate Sodium
Clopindal
Lacalocid
Nicarbazin
Salinomycin
Sulfachloropyrazine
Sulfaquinoxaline
Arsanilic Acid
Dequinate
Lasalocid
Novobiocin
Spectinomycin
Sulfachloropyridazin e
Sulfathiazone
Bacitracin
Dihydrostreptomyc in
Lincomycin
Oleandomyci n
Streptomycin
Sulfachlorpyidazine
Virginiamycin
Sulfadimethoxine
Zoalene
Mechanisms of resistance
The four most important antibiotic resistance mechanisms are 1. Alteration of the target site of the antibiotic 2. Enzyme inactivation of the antibiotic 3. Active transport of the antibiotic out of the bacterial cell, and 4. Decreased permeability of the bacterial cell wall to the antibiotic
Active transport of the antibiotic out of the bacterial cell Active transport systems (efflux pumps) have been described for the removal of some antibiotics (such as tetracyclines, macrolides, and quinolones) from bacterial cells. In these situations, even though the drug can enter the bacterial cell, active efflux of the agent prevents it from accumulating and interfering with bacterial metabolism or replication.
Bacteria are intrinsically resistant to many drugs based solely on the fact that the drugs cannot penetrate the bacterial cell wall or cell membrane. In addition, bacteria can acquire resistance to a drug by an alteration in the porin proteins (Porins are beta barrel proteins that cross a cellular membrane and act as a pore through which molecules can diffuse) that form channels in the cell membrane. The resistance that Pseudomonas aeruginosa exhibits to a variety of penicillins and cephalosporins is mediated by an alteration in porin proteins. Active transport of the antibiotic out of the bacterial cell
About 80% patients in rural areas are dependent on quacks ," said Ajay Kumar, secretary, Bihar State Health Services Association, at the seminar, adding, "indiscriminate and inadequate use of antibiotics by them is a major concern, and probably this is the major cause of developing antimicrobial resistance in the state."
In the late 1990s and 2000, WHO convened a series of consultative groups, expert workshops, and consensus meetings to assess the growing public health threat of antimicrobial resistance, to evaluate the impact of containment interventions, and to develop a series of recommendations for action. The culmination of this work was the publication in 2001 of the WHO Global Strategy for Containment of Antimicrobial Resistance and a series of supportive background materials and technical guidelines.
Conclusions
Increasing antibiotic resistance is a major threat to global public health National (and international surveillance) of resistance patterns is crucial to guide therapy; it also focuses the minds of clinicians, administrators and governments on the problem Excessive and inappropriate use of antibiotics occurs in all countries; this must be remedied at the national and local level Best-practice antibiotic guidelines coupled with drug audits, and other strategies can improve antibiotic use. The Internet and information technology holds promise for further improving prescribing in the future.
24
Hemant Shukla, regional team leader of the WHO, said on Thursday on the occasion of World Health Day "As a result of irrational use of antibiotic drugs in the last few decades, infections are no longer easily cured, leading to prolonged and expensive treatment and greater risk of death," .(TNN, Apr 7, 2011)
Overview
Trends in antimicrobial resistance Problems in developing drugs for resistant pathogens Focused development: one possible solution
26
Community
Penicillin-resistant S. pneumoniae (PRSP) Multidrug-resistant Salmonella (non-typhi)
27
0.1% 10-15% 8%
Mainous and Pomeroy (2001) 28 Extrapolation from Edmond et al. (1999) Clin Inf Dis 29:239-44
80
29
The search for new antibiotics Synthesis of new chemical entities Screening for new antibiotics Mammalian peptide antibiotics Peptide antibiotics from other organisms Revitalizing old antibiotics Altered peptide synthetases Alteration of peptide linkers Phenotypic conversion Carbohydrate-modified compounds Vaccines Genomic approaches Targeting virulence factors Other strategies to overcome antibiotic resistance Bacteriophage Non-antibiotics
Chlorhexidine
Application for more than one week can cause an increased resistance in S. mutans and S. sobrinus
Other effects
Liberal availability of antibiotics to non-professionals (foreign pharmacies, feed stores) Increasing numbers of immunocompromised individuals and the elderly Patient demand to treat viral conditions with antibiotics Increase in institutional care environments (same phenomenon in concentrated animal husbandry) International travel (disseminates resistant organisms rapidly)
Antimicrobial resistance
Resistance occurs due to:
Intrinsic ability (penicillinase in E Coli) Random genetic mutation Transfer of resistance on a plasmid (extra-chromosomal DNA)
Development of new antibiotics is slow and costly Prolonged illness and greater risk of death Greater risk of antibiotic resistant food borne illness (Salmonella DT-104, fluoroquinilone resistant Campylobacter)
Increased complexity of empiric antibiotic coverage Greater empiric use of antibiotics Increased use of broad spectrum antibiotics Perpetuates the cycle of resistance
Questions?